738 related articles for article (PubMed ID: 19426222)
1. The significance of OX40 and OX40L to T-cell biology and immune disease.
Croft M; So T; Duan W; Soroosh P
Immunol Rev; 2009 May; 229(1):173-91. PubMed ID: 19426222
[TBL] [Abstract][Full Text] [Related]
2. OX40 and OX40L Interaction in Cancer.
Lu X
Curr Med Chem; 2021; 28(28):5659-5673. PubMed ID: 33372866
[TBL] [Abstract][Full Text] [Related]
3. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
4. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
[TBL] [Abstract][Full Text] [Related]
5. Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells.
Burocchi A; Pittoni P; Gorzanelli A; Colombo MP; Piconese S
Eur J Immunol; 2011 Dec; 41(12):3615-26. PubMed ID: 22229156
[TBL] [Abstract][Full Text] [Related]
6. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer.
Redmond WL; Weinberg AD
Crit Rev Immunol; 2007; 27(5):415-36. PubMed ID: 18197805
[TBL] [Abstract][Full Text] [Related]
7. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
8. In Situ Reprogramming of Tumors for Activating the OX40/OX40 Ligand Checkpoint Pathway and Boosting Antitumor Immunity.
Gao Y; Zhao J; Huang Z; Zhao H; Guo Z; Ma S; Tang X; Song W; Chen X
ACS Biomater Sci Eng; 2023 Jul; 9(7):4108-4116. PubMed ID: 35653749
[TBL] [Abstract][Full Text] [Related]
9. Control of immunity by the TNFR-related molecule OX40 (CD134).
Croft M
Annu Rev Immunol; 2010; 28():57-78. PubMed ID: 20307208
[TBL] [Abstract][Full Text] [Related]
10. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
[TBL] [Abstract][Full Text] [Related]
11. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.
Gramaglia I; Jember A; Pippig SD; Weinberg AD; Killeen N; Croft M
J Immunol; 2000 Sep; 165(6):3043-50. PubMed ID: 10975814
[TBL] [Abstract][Full Text] [Related]
12. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
Mendel I; Shevach EM
Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
Takeda I; Ine S; Killeen N; Ndhlovu LC; Murata K; Satomi S; Sugamura K; Ishii N
J Immunol; 2004 Mar; 172(6):3580-9. PubMed ID: 15004159
[TBL] [Abstract][Full Text] [Related]
14. The role of OX40-mediated co-stimulation in T-cell activation and survival.
Redmond WL; Ruby CE; Weinberg AD
Crit Rev Immunol; 2009; 29(3):187-201. PubMed ID: 19538134
[TBL] [Abstract][Full Text] [Related]
15. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
Soroosh P; Ine S; Sugamura K; Ishii N
J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
[TBL] [Abstract][Full Text] [Related]
16. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
Wang HC; Klein JR
J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
[TBL] [Abstract][Full Text] [Related]
17. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
Kumar P; Marinelarena A; Raghunathan D; Ragothaman VK; Saini S; Bhattacharya P; Fan J; Epstein AL; Maker AV; Prabhakar BS
Cell Mol Immunol; 2019 Feb; 16(2):138-153. PubMed ID: 29578532
[TBL] [Abstract][Full Text] [Related]
18. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles.
Brocker T; Gulbranson-Judge A; Flynn S; Riedinger M; Raykundalia C; Lane P
Eur J Immunol; 1999 May; 29(5):1610-6. PubMed ID: 10359115
[TBL] [Abstract][Full Text] [Related]
19. Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.
Fromm G; de Silva S; Johannes K; Patel A; Hornblower JC; Schreiber TH
J Immunother Cancer; 2018 Dec; 6(1):149. PubMed ID: 30563566
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rat OX40 ligand by monoclonal antibody.
Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
